Arcutis Biotherapeutics, Inc. (ARQT) Revenue History
Arcutis Biotherapeutics, Inc. (ARQT) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | $3.69M |
| 2023-12-31 | $29.19M |
| 2024-12-31 | $166.54M |
| 2025-12-31 | $372.07M |
How ARQT compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| KRYS | Krystal Biotech Inc. | $389.13M |
| MNKD | MannKind Corporation | $348.97M |
| FLGT | Fulgent Genetics Inc. | $322.67M |
| EOLS | Evolus Inc. | $297.18M |
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
These are five companies in the same sector as ARQT with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Arcutis Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("ARQT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARQT | $25.40 | +2.17% | 0.78M |
| 3 | ||||
| 4 | ||||
| 5 |